|
業務類別
|
Biotechnology |
|
業務概覽
|
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization. |
| 公司地址
| 11750 Sorrento Valley Road, Suite 200, San Diego, CA, USA, 92121 |
| 電話號碼
| +1 302 355-0650 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.ibioinc.com |
| 員工數量
| 20 |
| Dr. Martin B. Brenner, PhD |
Director, Chief Executive Officer and Chief Scientific Officer |
美元 539.37K |
06/10/2025 |
| Mr. Marc Banjak |
Chief Legal Counsel |
美元 366.93K |
06/10/2025 |
| Mr. Felipe Duran |
Chief Financial Officer and Principal Accounting Officer |
美元 371.32K |
06/10/2025 |
|
|
| Mr. William D. Clark |
Chairman of the Board |
06/10/2025 |
| Mr. Gary L. Sender |
Independent Director |
06/10/2025 |
| Mr. Evert B. Schimmelpennink |
Independent Director |
06/10/2025 |
| Dr. Martin B. Brenner, PhD |
Director, Chief Executive Officer and Chief Scientific Officer |
06/10/2025 |
| Mr. David A. Arkowitz, M.B.A. |
Independent Director |
06/10/2025 |
| Dr. Alexandra Kropotova, M.D. |
Independent Director |
06/10/2025 |
| Mr. Antonio Bernardino Guimaraes Parada |
Independent Director |
06/10/2025 |
|
|
|
|
